Blog

NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis (PsO) submitted to U.S. FDA in July

ANTHEM Phase 2b trial data of icotrokinra in ulcerative colitis scheduled for an oral presentation at the 33^rd United European Gastroenterology Week (UEGW) on October 7^th

Phase 3 VERIFY trial data set of rusfertide in polycythemia vera (PV) presented during plenary session at ASCO; U.S. NDA filing on track for Q4

Cash, cash equivalents and marketable securities of $673.0 million as of June 30, 2025, anticipated to provide cash runway through at least end of 2028

NEWARK, CA / ACCESS Newswire / August 6, 2025 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the second quarter ended June 30, 2025, and provided a corporate update.

“Thus far, 2025 has been a year of breakthrough accomplishments for Protagonist, as we saw rusfertide the topic of the prestigious ASCO Plenary Session in May, the announcement of an oral and injectable triple agonist anti-obesity peptide development candidate in June, and most recently the first ever NDA filing of icotrokinra for psoriasis last month,” said Dinesh V. Patel, Ph.D., the Company’s President and CEO. “Over the coming months, we look forward to the NDA filing of rusfertide for polycythemia vera, and advancing our wholly owned early-stage assets PN-881 and PN-477 into clinical and IND-enabling studies respectively.”

Second Quarter 2025 Recent Developments and Upcoming Milestones

Rusfertide: Subcutaneous Injectable Hepcidin Mimetic for Polycythemia Vera (PV) and Other Blood Disorders

• Cash, Cash Equivalents and Marketable Securities: Cash, cash equivalents and marketable securities as of June 30, 2025, were $673.0 million as compared to $559.2 million as of December 31, 2024.

		Three Months Ended								Six Months Ended
		June 30,								June 30,
(in thousands, except per share amounts)		2025				2024				2025				2024
		(Unaudited)
License and collaboration revenue		$	5,546			$	4,167			$	33,867			$	259,120
Research and development expense		$	37,036			$	33,520			$	72,929			$	67,254
General and administrative expense		$	10,551			$	9,440			$	22,289			$	24,350
Net (loss) income		$	(34,771	)		$	(30,616	)		$	(46,426	)		$	176,724
Basic (loss) earnings per share		$	(0.55)			$	(0.50)			$	(0.73)			$	2.89
Diluted (loss) earnings per share		$	(0.55)			$	(0.50)			$	(0.73)			$	2.77

• License and Collaboration Revenue:

  • License and collaboration revenue of $5.5 million and $4.2 million for the second quarter of 2025 and 2024, respectively, was comprised of development services we provided under the Takeda collaboration agreement.

  • License and collaboration revenue of $33.9 million for the six months ended June 30, 2025 was comprised of (i) proportional recognition of a $25 million milestone earned from Takeda in Q1 25, and (ii) development services we provided during the period. License and collaboration revenue of $259.1 million for the six months ended June 30, 2024 included (i) $254.1 million of the $300.0 million initial transaction price for the Takeda collaboration agreement allocated to the rusfertide license upon effectiveness of the agreement, and (ii) development services we provided during the period.

• Research and Development (“R&D”) Expense: The increases in R&D expense from the prior year periods were primarily due to increases in pre-clinical and drug discovery research expenses, including costs related to our new product candidates, IL-17 oral peptide antagonist PN-881 and obesity triple agonist peptide PN-477, partially offset by decreases in rusfertide expenses related to the Phase 3 VERIFY clinical trial.

• General and Administrative (“G&A”) Expense: The increase in G&A expense for the second quarter of 2025 from the prior year period was primarily due to increases in stock-based compensation and other personnel-related expenses. The decrease in G&A expense for the six months ended June 30, 2025 from the prior year period was primarily due to $4.6 million in advisory and legal fees recognized in 2024 related to the Takeda collaboration, partially offset by increases in stock-based compensation expense and other personnel-related expenses.

• Net (Loss) Income: Net loss was $34.8 million, or $0.55 per basic and diluted share, for the second quarter of 2025 as compared to net loss of $30.6 million, or $0.50 per basic and diluted share, for the second quarter of 2024. Net loss was $46.4 million, or $0.73 per basic and diluted share, for the six months ended June 30, 2025 as compared to net income of $176.7 million, or $2.89 per basic share and $2.77 per diluted share, for the six months ended June 30, 2024, which included recognition of $259.1 million revenue related to the Takeda collaboration agreement upfront payment of $300.0 million.

About Protagonist

Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist’s proprietary discovery platform are currently in advanced Phase 3 clinical development, with a New Drug Application (NDA) for icotrokinra submitted to the FDA in July and an NDA submission for rusfertide expected by end of 2025. Icotrokinra (formerly, JNJ-2113), a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor (“IL-23R”) is licensed to J&J Innovative Medicines (“JNJ”), formerly Janssen Biotech, Inc. Following icotrokinra’s joint discovery by Protagonist and JNJ scientists pursuant to the companies’ IL-23R collaboration, Protagonist was primarily responsible for development of icotrokinra through Phase 1, with JNJ assuming responsibility for development in Phase 2 and beyond. Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered in 2024 under which the Company remains primarily responsible for development through NDA filing. The Company also has a number of pre-clinical stage drug discovery programs addressing biologically and commercially validated targets, including IL-17 oral peptide antagonist PN-881, obesity triple agonist peptide PN-477, and the oral hepcidin program.

More information on Protagonist, its pipeline drug candidates and clinical studies can be found on the Company’s website at https://www.protagonist-inc.com/.

Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the potential benefits of icotrokinra and rusfertide, the timing of icotrokinra and rusfertide clinical trials, and timing of developments and announcements in our discovery programs. In some cases, you can identify these statements by forward-looking words such as “anticipate,” “believe,” “may,” “will,” “expect,” or the negative or plural of these words or similar expressions. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, our ability to develop and commercialize our product candidates, our ability to earn milestone payments under our collaboration agreements with Janssen and Takeda, our ability to use and expand our programs to build a pipeline of product candidates, our ability to obtain and maintain regulatory approval of our product candidates, our ability to operate in a competitive industry and compete successfully against competitors that have greater resources than we do, and our ability to obtain and adequately protect intellectual property rights for our product candidates. Additional information concerning these and other risk factors affecting our business can be found in our periodic filings with the Securities and Exchange Commission, including under the heading “Risk Factors” contained in our most recently filed periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Investor Relations Contact

Corey Davis, Ph.D.
LifeSci Advisors
cdavis@lifesciadvisors.com
+1 212 915 2577

Media Relations Contact

Virginia Amann
ENTENTE Network of Companies
virginiaamann@ententeinc.com
+1 833 500 0061 ext 1

PROTAGONIST THERAPEUTICS, INC.
Condensed Consolidated Statements of Operations
(Unaudited)
(Amounts in thousands except share and per share data)

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2025				2024				2025				2024
License and collaboration revenue		$	5,546			$	4,167			$	33,867			$	259,120
Operating expense:
Research and development (1)			37,036				33,520				72,929				67,254
General and administrative (1)			10,551				9,440				22,289				24,350
Total operating expense			47,587				42,960				95,218				91,604
(Loss) income from operations			(42,041	)			(38,793	)			(61,351	)			167,516
Interest income			7,406				7,404				14,979				11,780
Other income, net			36				97				118				78
(Loss) income before income tax expense (benefit)			(34,599	)			(31,292	)			(46,254	)			179,374
Income tax expense (benefit)			172				(676	)			172				2,650
Net (loss) income		$	(34,771	)		$	(30,616	)		$	(46,426	)		$	176,724
Net (loss) income per share, basic		$	(0.55	)		$	(0.50	)		$	(0.73	)		$	2.89
Net (loss) income per share, diluted		$	(0.55	)		$	(0.50	)		$	(0.73	)		$	2.77
Weighted-average shares used to compute net (loss) income per share, basic			63,510,537				61,305,289				63,238,682				61,080,489
Weighted-average shares used to compute net (loss) income per share, diluted			63,510,537				61,305,289				63,238,682				63,909,633

(1) Amount includes non-cash stock-based compensation expense.

Stock-based Compensation
(Unaudited, in thousands)

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2025				2024				2025				2024
Research and development		$	6,291			$	5,097			$	14,282			$	10,385
General and administrative			4,621				3,847				10,432				7,911
Total stock-based compensation expense		$	10,912			$	8,944			$	24,714			$	18,296

PROTAGONIST THERAPEUTICS, INC.
Selected Condensed Consolidated Balance Sheet Data
(Unaudited, In thousands)

		June 30,				December 31,
		2025				2024
Cash, cash equivalents and marketable securities$			672,958			$	559,165
Working capital			567,019				544,243
Total assets			718,006				744,725
Deferred revenue			20,063				30,567
Accumulated deficit			(386,948	)			(340,522	)
Total stockholders’ equity			668,018				675,295

SOURCE: Protagonist Therapeutics

View the original press release on ACCESS Newswire

90+ medical professionals gather in Sioux Falls for hands-on training, real-time telemedicine support, and continuing education through AVELearn

SIOUX FALLS, SD / ACCESS Newswire / August 6, 2025 / Over 90 medical professionals from across the country gathered in Sioux Falls for the 2025 Avel eCare Emergency Airway Training Program, powered by The Difficult Airway Course™. This immersive, two-day program combined classroom instruction with high-impact, hands-on practice to help clinicians build confidence and precision in one of the most critical emergency procedures-intubation.

A standout feature of the course was the use of over 100 porcine tracheas, allowing participants to practice surgical and video-guided airway techniques on a wide variety of anatomies. These real tracheas replicate the diverse challenges clinicians face in real-world airway emergencies, helping providers build muscle memory and quick-response capability.

“Every airway is different, and every second matters,” said Dr. Kelly Rhone, Chief Medical Officer at Avel eCare. “This course gives physicians the repetition and exposure they need to act decisively and safely when it counts.”

The training also highlighted Avel’s real-time telemedicine support, including the use of video laryngoscopes-specialized tools with mounted cameras. These allow remote Avel physicians to see exactly what on-site providers see during a live intubation and verbally guide them step-by-step.

“It’s not just about teaching intubation,” added Dr. Rhone. “It’s about being there-virtually-during the most critical seconds, helping physicians feel confident, supported, and prepared.”

For some, the impact of the course has already been felt in the field.

“I had to perform a surgical cricothyrotomy for the first time in the ER. I definitely would not have felt comfortable even attempting it before I had taken this course,” said Bryon Bellinger, ARNP, of Guttenberg Municipal Hospital. “I was also fortunate to have an Avel physician on camera helping me with it as well. I recommend [the course] to everyone.”

Course highlights included:

• Pediatric Airway Case Discussions

• Surgical Airway Techniques

• Bag-Valve Mask and Laryngoscopy Workshops

• Code Airway Simulations

• Video Laryngoscopy Skill Stations

But training doesn’t stop at the end of the workshop. Avel eCare is committed to continuing education through its AVELearn platform, which provides ongoing access to clinical webinars, simulated learning, and accredited courses.

“Beyond airway training, Avel eCare’s AVELearn platform provides a wide range of education opportunities tailored to the unique needs of our partners. Whether it’s accessing credit hours online, participating in live webinars, or engaging in simulated education, Avel eCare ensures that continuing education is accessible, practical, and integrated into our partnership” said Dr. Luke Van Oeveren, Avel eEmergency Physician.

For Avel, this event reflects a broader mission: to empower clinicians with the tools, training, and telemedicine technology they need-whether they’re in a metro trauma center or a rural ER.

About Avel eCare
Avel eCare is one of the nation’s leading telemedicine providers, delivering 24/7 virtual clinical support across emergency care, ICU, behavioral health, pharmacy, hospitalist, and specialty services. Through innovative programs like AVELearn, Avel supports continuous education and skill development for healthcare teams, helping them deliver consistent, high-quality care-anytime, anywhere. Learn more at avelecare.com/education.

Media Contact:
Jessica Gaikowski
Avel eCare
media@avelecare.com

SOURCE: Avel eCare

View the original press release on ACCESS Newswire

Indiana company says new drone regulations will speed improvements to package delivery security for Americans

INDIANAPOLIS, IN / ACCESS Newswire / August 6, 2025 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network anchored by patented AI-powered Arrive Points™, celebrated the Trump administration’s proposed new rule regarding drones flying Beyond Visual Line of Sight (BVLOS), that it said would unleash American innovation and safely integrate unmanned aircraft systems (UAS) into the national airspace system.

The proposed rule would eliminate individual flight waivers and introduce key safety roles like Operations Supervisor and Flight Coordinator, helping commercial drone flights take off nationwide. U.S. Transportation Secretary Sean P. Duffy said the move would “unleash American drone dominance.”

The announcement, made late yesterday, comes as Arrive AI is poised to roll out its solution for longstanding issues of security within the package delivery industry, a $191 billion market in the U.S. alone. Arrive AI’s patented Arrive Points anchor the company’s connected delivery network and proprietary technology, which enables secure, verifiable, and contactless delivery for drone, ground robot, or traditional human driver. The platform provides a secure chain-of-custody, ensuring every delivery is tracked and authenticated from the moment it enters an Arrive Point until it is retrieved.

“This is a watershed moment,” said Dan O’Toole, founder and CEO of Arrive AI. “The proposed BVLOS rule brings us significantly closer to a future where drones, robots and AI-powered, smart delivery points work together to move goods securely, efficiently, and autonomously, particularly in healthcare, public safety, and rural last-mile logistics.”

Arrive AI officials have long sought to loosen federal restrictions in the industry. “Other countries are ahead of us in using drones for delivery, and in the few cases in the U.S. where it’s been allowed, consumers love it,” O’Toole said.

Arrive AI is already working with Skye Air Mobility, India’s dominant and rapidly expanding hyperlocal drone delivery platform. Skye Air currently makes about 6,000 deliveries per day in suburban New Delhi. The companies expect to have 500 Arrive Points across Skye Air’s service areas in the future, serving a population exceeding 33 million.

FAA Administrator Bryan Bedford said normalizing drone flights “is key to realizing drones’ societal and economic benefits” for package delivery” and other uses.

O’Toole said he is eager to see the rule approved and for Americans to have the same fast, convenient, more sustainable form of delivery.

“This is the way of the future,” he said. “Arrive AI will make that last inch of the delivery process so much better for the delivery industry as well as users, who’ll be able to receive and return items with the touch of a button. They’re ready for this, and so are we.”

-30-

About Arrive AI

Arrive AI’s patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at www.arriveai.com and via the company’s press kit.

Media contact: Cheryl Reed at media@arriveai.com

Investor Relations media@arriveai.com

Contact: Alliance Advisors IR at ARAI.IR@allianceadvisors.com

Cautionary Note Regarding Forward Looking Statements

This news release and statements of Arrive AI’s management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “potential”, “will”, “should”, “could”, “would”, “optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI’s Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

SOURCE: Arrive AI Inc.

View the original press release on ACCESS Newswire

OAKVILLE, ONTARIO / ACCESS Newswire / August 6, 2025 / Consumer Choice Award is pleased to announce the 2025 award recipients in the Halton Region. These businesses have been meticulously selected through independent market research, reflecting their commitment to excellence and unparalleled service in their city. Consumer Choice Award celebrates those who have consistently set the benchmark for quality and customer satisfaction. Congratulations to the 2025 Halton Region Consumer Choice Award Winners.

HALTON REGION AWARD RECIPIENTS

Academy for Mathematics & English Tutoring www.tutoringacademy.ca/burlington www.tutoringacademy.ca/glenabbey	Bullard Brothers Painting Painting Contractor www.oakvillepainting.ca
Global Citizen Uniforms and Promotional Products Promotional Products www.globalcitizen.ca/en	Instaboothgta Photo Booth Rentals www.instaboothgta.ca
JSN Appliances Repair Inc Home Appliance Service www.jsnappliances.ca	MinMaxx Realty Inc., Brokerage Real Estate – Residential www.minmaxx.com
National Wines Wine Agency www.nationalwines.ca	Oakville Academy For The Arts School – Dance/ Music www.oakvilleacademy.com
Safe n Sound Environmental Services Ltd. Asbestos Removal www.safensoundenvironmentalservices.ca	Smart Repair Centre Automobile Body Shop www.smartrepaircentre.ca
VIP Hairlines Hair Restoration www.viphairlines.com	Work-Fit Total Therapy Centre Pain & Rehabilitation Therapy www.workfitphysiotherapy.ca

Learn more about 2025 Halton Region Consumer Choice Award Winners HERE.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

Expanding Nexscient’s Global Portfolio of AI-Powered Platforms and Services

LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Nexscient, Inc. (OTCQB:NXNT), a leading innovator in artificial intelligence (“AI”) applications and intelligent enterprise solutions, announced today that it has executed a non-binding Letter of Intent (LOI) to acquire substantially all of the assets of Flipside Digital Content Company, Inc., a Philippines-based provider of high-quality data labeling, annotation, and digital transformation services (“Flipside AI”). This acquisition marks a significant step in Nexscient’s strategy to build a global portfolio of AI-powered platforms and services.

Under the terms of the LOI, Nexscient will acquire substantially all of Flipside AI’s operating assets for a total consideration of approximately $5.94 million, consisting of a combination of cash, a convertible debenture, and Nexscient restricted common stock. In addition to assuming key operating liabilities, Nexscient will also make a capital investment over subsequent years to support Flipside AI’s continued growth and expansion. As part of the transaction, Flipside President and CEO Anthony De Luna will enter into a five-year executive employment agreement and continue leading the newly formed subsidiary. He will also be appointed to the Board of Directors of Nexscient, Inc.

“We are thrilled to welcome Flipside AI into the Nexscient family,” said Fred E. Tannous, President and CEO of Nexscient, Inc. “This acquisition enhances our capabilities in data labeling and annotation – key components of the AI data training pipeline. Generating over $9.2 million in revenues over the last four years from clients all around the world, Flipside AI’s proven expertise and scalable operations in Southeast Asia will accelerate our global expansion while deepening our commitment to supporting enterprise AI across industries including healthcare, agriculture, automotive, and robotics.”

“Joining Nexscient represents an exciting new chapter for Flipside,” added Anthony De Luna, President and CEO of Flipside AI. “This partnership provides the strategic capital, international platform, and executive leadership to take our AI data services business to new heights. Together, we aim to become a global force in providing transformative data solutions.”

The global AI data training market is projected to grow substantially, rising from an estimated $12.7 billion in 2024 to $92.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 22%¹. This surge closely mirrors the anticipated increase in AI system spending worldwide, which is expected to reach $632 billion by 2028, representing a 29% CAGR over the 2024-2028 forecast period². In parallel, the global data annotation tools market, valued at $2.02 billion in 2023, is forecasted to expand at a CAGR of 31.1%, reaching $23.11 billion by 2032³. These trends underscore the critical role of high-quality data in scaling AI capabilities across industries.

¹ Data Labeling Solution and Services Market, FactMR (Apr. 2024)

² Worldwide Artificial Intelligence Systems Spending Guide, IDC (Aug. 2024)

³ Data Annotation Tools Market, Astute Analytica, (Nov. 2024)

About Nexscient, Inc.

Nexscient [OTCQB: NXNT] is an emerging-growth company that’s building a global collaborative network of intelligent enterprise applications and technologies through internal development, synergistic acquisitions, and capital investments in companies involved in machine learning, artificial intelligence, and the Industrial Internet of Things technologies. As part of our growth strategy, we also seek to acquire and integrate synergistic AI and machine learning companies and technologies into our collaborative network, further expanding our service offerings while enhancing shareholder value. For more information, please visit https://nexscient.ai.

About Flipside Digital Content Company, Inc.

Flipside AI is a premier data engineering company that blends top-tier human expertise with advanced technologies to deliver high-quality data annotation and transformation services. We empower global enterprises across diverse industries to unlock the full potential of their data, enabling them to develop fast, accurate, and scalable AI applications. For more information, please contact us at flipside@nexscient.com

Forward-Looking Statements

This release contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Nexscient, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy; and (iv) performance of our products and services. You can identify these statements by the use of the words “may,” “will,” “could,” “should,” “would,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” “likely,” “forecast,” “probable,” “potential,” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Nexscient’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. These risks and uncertainties also include such additional risk factors as are discussed in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2024, Forms 10-Q and 8-K, and in other filings we make with the Securities and Exchange Commission from time to time. These documents are available on the SEC Filings section of the Investor Relations section of our website at https://nexscient.ai. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.

#######

COMPANY CONTACT:

Nexscient, Inc.
Fred E. Tannous, President & CEO
Email: press@nexscient.com
Phone: +1 (310) 494-6620
Web: www.nexscient.com

SOURCE: Nexscient, Inc.

View the original press release on ACCESS Newswire

New Jersey commercial solar provider recognized by Solar Power World for seventh consecutive year

MAHWAH, NJ / ACCESS Newswire / August 6, 2025 / Core Development Group, a nationally ranked, independent, trusted clean energy provider, has ranked number 16 as the commercial contractor in the nation on Solar Power World‘s prestigious 2025 Top Solar Contractors List. Based on 2024 installed capacity (in kWDC), Core Development Group was at the top of the lists in 6 states, including ranked 16^th overall in New Jersey, 44^th in New York, and 7^th in Connecticut. This marks the seventh consecutive year that Core Development Group has made the rankings.

Solar Power World chooses its annual list of Top Solar Contractors based on the total number of solar kilowatts installed, geographic reach, and market influence. Receiving this prestigious accolade for the seventh consecutive year underscores Core Development Group’s dedication to excellence, innovation, and sustainability in the clean energy sector. The Top Solar Contractors List is the most recognized annual listing of solar firms in the utility, commercial, community, and residential markets.

“Since our inception, we’ve been committed to helping businesses and organizations adopt cleaner and more affordable solar power solutions,” said Henry Cortes, founder and CEO of Core Development Group. “Solar Power World’s ranking of Core Development Group as a top commercial solar contractor reinforces our strong position in the solar industry and reflects our relentless drive to put our customers first and deliver operational excellence. As we continue to grow, we remain committed to our customers and stabilizing their energy budgets, reducing long-term energy costs and lowering their carbon footprint at the same time.”

Core Development Group has multiple commercial solar and battery energy storage system (BESS) projects in the pipeline. Solar power generation and battery storage add flexibility to any sustainable energy solution and are key to clean energy deployment across the USA.

“From the smallest residential projects to the largest utility-scale solar farms, these installations are keeping the lights on and keeping power affordable. We’re thrilled to recognize another outstanding class of Top Solar Contractors,” said Kelsey Misbrener, managing editor of Solar Power World.

As a full-service commercial solar company, Core Development Group manages the entire solar energy process. The past year was a banner year for the company, marked by a comprehensive portfolio of successful solar and battery projects. These installations not only enhance energy efficiency and lower carbon emissions but also deliver budget stability or cost savings to clients.

About Core Development Group
Core Development Group is a trusted and agile independent U.S. renewable energy developer, contractor, and consultant. The company helps organizations transition to clean, renewable energy and provides solar energy systems, battery storage, microgrids, and EV charging infrastructure to companies in the U.S. and abroad. Core Development Group also provides world-class engineering, design, construction, quality assurance, and construction management consulting services for renewable energy projects. Founded in 2012, Core Development Group is headquartered in Mahwah, New Jersey. Learn more at coredevusa.com.

About Solar Power World
Solar Power World is the leading online and print resource for news and information regarding solar installation, development and technology. Since 2011, SPW has helped U.S. solar contractors – including installers, developers, and EPCs in all markets – grow their businesses and do their jobs better.

About the Top Solar Contractors List
The Top Solar Contractors List is the most recognized annual listing of solar contractors in the United States. It is compiled annually by industry magazine Solar Power World to recognize the work of solar installers to decarbonize the grid and support home-grown, local energy. Companies on the Top Solar Contractors List are grouped and listed by specific service, market (commercial, community solar, residential, utility), and state by 2024 installed capacity (in kWDC). See all the 2025 winners.

Contact Information

Bill Collins
Marketing Manager Core Development Group
bcollins@coredevusa.com

Kelly Pickerel
Editor in Chief Solar Power World
kpickerel@wtwhmedia.com

SOURCE: Core Development Group LLC

View the original press release on ACCESS Newswire

MISSISSAUGA, ONTARIO / ACCESS Newswire / August 6, 2025 / Consumer Choice Award is pleased to announce the 2025 award recipients in the Peel Region. These businesses have been meticulously selected through independent market research, reflecting their commitment to excellence and unparalleled service in their city. Consumer Choice Award celebrates those who have consistently set the benchmark for quality and customer satisfaction. Congratulations to the 2025 Peel Region Consumer Choice Award Winners.

PEEL REGION AWARD RECIPIENTS

A R Business Brokers Inc., Brokerage. Business Brokers www.aldrin.ca	Altima Kitchens and Closets Kitchen and Bathroom Renovator www.altimakitchensandclosets.com
Astra Medicare Cosmetic Procedure www.astramedicare.ca	Atlas Auto Collision Center Brampton Automobile Body Shop www.atlasautocollision.com
Bella Turf Artificial Grass www.bellaturf.ca	Blackstone Steakhouse & Grill Restaurants/ Steakhouse www.blackstonesteakhouse.ca
City Gate Suites Short Term Rentals Executive Suites www.citygatesuites.com	Epic Baskets Gift Baskets www.epicbaskets.com
Forever Green Lawn & Landscape Landscape Contractor www.forevergreeninc.ca	Gold Cherry Bakery Cake Shop www.goldcherrybakery.ca
Gord’s Basement Waterproofing Ltd Waterproofing and Foundation Repair www.gordsbasementwaterproofing.ca	Greater Toronto Accessibility Accessibility Contractors www.greatertorontoaccessibility.com
Guru Lukshmi Restaurants – Indian Cuisine www.gurulukshmi.com	Hair Transplant Medical Centre | Hair Loss Treatment Mississauga Hair Restoration www.hair-transplant.ca
Heartland International English School Schools – Languages www.heartlandenglish.com	iTechSkills Academy Computer Training www.itechskills.ca
John The Plumber Plumbing Contractor www.johntheplumber.ca	JSN Appliances Repair Inc Home Appliance Service www.jsnappliances.ca
Little Galaxy Childcare & Montessori Daycare www.littlegalaxycc.com	MNP Ltd. Licensed Insolvency Trustee www.mnpdebt.ca/en/offices/brampton-mount-pleasant
Mobile Pet S’Paw Pet Grooming www.mobilepetspaw.ca	MPR Landscapes Landscape Design www.mprlandscapes.com
MyFire Protection Inc. Fire & Sprinkler Safety Systems www.myfireprotection.ca	Nails R Us Supply Cosmetology Nails & Beauty Supplies www.nailsrus.ca
Perera Law – Real Estate Lawyer Real Estate Law www.pereralaw.ca	Powerflow Chiropractic Chiropractors www.drbhasin.com
Puppy Academy Pet Training www.puppyacademy.ca	Real Blue Roofing Services Inc. Brampton Roofing Repair www.realblueroofing.ca
Rejuva Medi Spa Medical Spa www.rejuvamedispa.com	Resolution Fitness Fitness Equipment Sales and Service www.resolutionfitness.ca
Richards Upholstery Upholsterers www.richardsupholstery.com	Ridgeline Services Inc. Roofing www.ridgelineservices.ca
S.A. Signs & Wraps in Mississauga Signs www.sasigns.ca	Save Tax Solutions Accountant – Small Business www.savetaxsolutions.com
The Fang and Flower Tattoo and Piercing Studio Tattoo Parlour www.thefangandflower.com	The Notary Guy Notary Services www.thenotaryguy.ca
The Place – Elmacan Wedding Venues www.elmacan.com	Tire World Automobile Tires www.tireworldbrampton.com
Tropical Orthodontics Orthodontists www.tropicalorthodontics.com	Vitalize Pilates Studio Pilates Studio www.vitalizepilatesstudio.com

Learn more about 2025 Peel Region Consumer Choice Award Winners HERE.

About Consumer Choice Award:

Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:

Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

What’s New for 2026?

ATLANTIC CITY, NJ / ACCESS Newswire / August 6, 2025 / DealFlow Events today announced the launch of the DealFlow Discovery Conference, an expanded version of its flagship event formerly known as The Microcap Conference. Set to take place at the Borgata Hotel & Casino in Atlantic City, January 28-29, 2026, the newly branded conference reflects a broader focus on capital formation – now welcoming both public and private high-growth companies to connect with investors, strategic partners, and capital markets professionals.

While the name has changed, the mission remains the same: to connect emerging companies with institutional and retail investors in an investment-focused environment. The 2026 event will be the largest yet, offering unlimited one-on-one meetings, expert-led discussions, and unmatched networking.

“The DealFlow Discovery Conference is where high-growth companies come to be discovered,” said Steven Dresner, Founder of DealFlow Events. “This evolution of the Microcap Conference was driven by what investors want – more access to pre-IPO and late-stage private companies.”

What’s New for 2026

This conference opens the door to a wider range of investment opportunities, expanding beyond public microcap companies to feature:

• Venture-Backed Companies – early-stage innovators raising capital and seeking strategic relationships

• Private Equity-Backed (Pre-IPO) Companies – growth-stage businesses preparing for the public markets

• Public Companies – U.S.-listed issuers focused on investor engagement and capital raising

• Foreign Companies – international firms seeking U.S.-based capital and exposure

This expansion responds to a growing trend: institutional interest in private market opportunities. By including private and pre-IPO companies, the DealFlow Discovery Conference is now even more valuable for investors – and for companies looking to raise capital.

Attendees can still expect the high standards, streamlined format, and energy that have defined the event since its inception. For those who’ve attended in the past, it’s a bigger, broader version of the conference they already trust. For new participants – especially private companies – it’s a chance to connect directly with serious investors in a format built for fundraising.

For more information and to apply to attend or present, visit www.DealFlowDiscoveryConference.com.

Media Contact:

Phillip LoFaso
phillip@dealflowevents.com
(516) 876-8006

SOURCE: DealFlow Events

View the original press release on ACCESS Newswire

Expands AI-ready Atlas Data Vault to >20B Global Electricity, Transport and Weather Records

OTTAWA, ON / ACCESS Newswire / August 6, 2025 / BluWave-ai announced significant milestones in the company’s intellectual property and data capabilities. The Ottawa-based company is a leading provider of artificial intelligence (AI) software for renewable energy and transport electrification at the forefront of the global energy transition. BluWave-ai has expanded its patent portfolio to 11 patents granted and 43 patent applications filed in various countries, alongside growing the proprietary BluWave-ai Atlas data platform to over 20 billion AI pre-processed records.

These achievements underscore the company’s innovation in developing the software systems critical for the future of renewable energy and electric transport. The expanded patent portfolio protects the company’s cutting-edge technologies using AI to optimize energy grids, manage electric vehicle (EV) charging, and enhance energy storage. This patent portfolio serves as a foundational strategy to manage the fluctuating grid-level electricity load and renewable generation with batteries and EVs, a capability that will be increasingly required by system operators globally as EV and renewable deployment continues around the world.

As of the end of 2024, the global EV fleet had reached almost 58 million vehicles, a number projected to surpass 250 million vehicles by 2030 (Source: Neklar, July 2025). This growth will be complemented by significant expansion in renewable energy infrastructure, with global wind power capacity projected to reach around 2,100 GW by 2030 (Source: Ember, August 2024, citing IEA, BNEF, and GWEC forecasts) and solar power capacity expected to exceed 7,000 GW by 2030 (Source: SolarPower Europe, May 2025).

The massive scale of the BluWave-ai Atlas data platform complements the company’s innovative technologies by providing an unparalleled foundation for training and deploying highly accurate AI models. This powerful combination of cutting-edge AI and a robust data infrastructure ensures the solutions from BluWave-ai are not only groundbreaking, but also highly effective and scalable, enabling superior performance and faster deployment, delivering significant value to clients from day one worldwide.

“Our continued growth in both patent protection and data scale reflects our unwavering commitment to empowering the global energy transition,” said Devashish Paul, CEO of BluWave-ai. “By securing our innovations and building an immense, AI-ready data foundation, we are accelerating the development and deployment of solutions that make renewable energy more reliable and electric transportation more efficient. This positions us as the foundational tech provider to the electricity and electrified transport industry for managing energy in real time.”

“BluWave-ai’s innovative technologies are empowering the global evolution of traditional electrical grids toward more sustainable, efficient, and resilient software-defined smart grids in the face of growing energy demands and climate changes,” said Thomas Triplet, VP of Technology at BluWave-ai, “Our portfolio covers foundational inventions of AI driven systems management for our utility and transport customers.”

Adding to this sentiment, Mike McLean, CEO of Innovation Asset Collective, stated, “At IAC, we know that when innovators own their ideas, they unlock real growth. This equips Canadian businesses with the funding, tools, and knowledge to prioritize IP ownership, and compete on the global stage.”

“BLG is proud to work with this exciting, dynamic Canadian success story, assisting BluWave-ai to build a robust and diverse IP portfolio, to mine and protect their multiple innovations, to increase their shareholder value, and to open up new opportunities nationally and overseas,” said Jeff Coghlan, lawyer and partner at the Canadian law firm BLG, “BluWave’s strong and growing patent portfolio is a validation of its cutting-edge technology. We look forward to expanding our collaboration with BluWave-ai, as the company ushers in a new era of energy transition and transportation electrification.”

The patent portfolio is embedded in the advanced AI-powered software platform of BluWave-ai which is designed to address key real time challenges in the electricity sector, supporting its product initiatives in:

• Smart Grid Optimization: This AI platform revolutionizes energy grid management, allowing utilities, independent power producers, and system operators to optimize renewable energy assets, predict energy demand, and make data-driven decisions in real-time. This leads to reduced operational costs, lower carbon footprints, and enhanced grid stability.

• EV Everywhere: Empowers EV drivers with intelligent control over their charging, optimizing energy consumption for cost savings and reduced carbon emissions. It intelligently shifts charging to align with lower electricity rates and cleaner energy sources, while also supporting grid stability through demand response capabilities.

• EV Fleet Orchestrator: Designed for electrifying fleet operations, this product intelligently manages EV fleet charging and dispatch. By integrating factors like energy price, peak demand constraints, and local generation from solar and battery energy storage and vehicle schedules, it optimizes energy use across mixed fleets, significantly reducing operating costs and emissions.

• Energy Storage Autopilot: This AI-driven platform provides automated, real-time optimization for battery energy storage systems (BESS). It is grid-aware, enabling BESS to participate effectively in energy markets, manage peak demands, and seamlessly integrate fluctuating renewable energy sources, maximizing the value and lifespan of energy storage assets.

With a growing global footprint globally deployed in Japan, the Middle East, India, Europe, and throughout North America, BluWave-ai is poised to continue its leadership in building the intelligent software foundation essential for a sustainable, electrified future.

Customers can access the company’s extensive patent portfolio and the BluWave-ai Atlas data platform through product purchases, or directly via an IP usage license for specific applications.

Additionally, customers may acquire direct licenses to use the BluWave-ai Atlas data platform via a SaaS subscription model.

Contact:

Brandon Paul
Senior Corporate Marketing Manager
Email: info@bluwave-ai.com

SOURCE: BluWave-ai

View the original press release on ACCESS Newswire

WHITBY, ON / ACCESS Newswire / August 6, 2025 / Consumer Choice Award is pleased to announce the 2025 award recipients in the Durham Region. These businesses have been meticulously selected through independent market research, reflecting their commitment to excellence and unparalleled service in their city. Consumer Choice Award celebrates those who have consistently set the benchmark for quality and customer satisfaction. Congratulations to the 2025 Durham Region Consumer Choice Award Winners.

DURHAM REGION AWARD RECIPIENTS

A R Business Brokers Inc., Brokerage. Business Brokers www.aldrin.ca	Anchor Point Fusion Bar & Grill Restaurants – Pub/Sports Bar www.anchorpointcourtice.com
AZON Bookkeeping Services Inc. Payroll Services www.azonbookkeepingservices.com	Captain Electric Electrical Contractor / Electrician www.captainelectric.ca
Colin’s Roofing & Eavestrough Eavestroughs www.colinsroofing.ca	Counter Reactions Counter Tops www.counterreactions.com
Double Diamond Air Duct Cleaning Duct and Furnace Cleaning www.doublediamondduct.ca	Durham First Aid Inc. Health & Safety Training www.durhamfirstaid.com
Durham Osteopathy Osteopathy www.durhamosteopathy.ca	Durham Travel Travel Agencies www.durhamtravel.ca
Emerald Professional Painters Painting Contractor www.emeraldpainting.ca	F45 Training Health and Fitness Centre www.f45training.com/ca/studio/ajaxcentral/
Harmony Creek Golf Centre Ltd Golf Courses – Public www.harmonycreekgolf.com	Hawley Crescent Catering & Events Caterers www.hawleycrescent.ca
JH Party & Tent Rentals Party Equipment Rental www.jhpartyrentals.com	Jubilee Pavilion Banquet & Conference Centre Wedding Venues www.jubileepavilion.ca
Michaela Mary Photography Photographer – Commercial www.michaelamary.com	Mo’s Auto Body and Restoration Automobile Body Shop www.mosautobodyandrestoration.com
Ontario Truck Training Academy Driving School Truck www.otta.ca	Oshawa Dental House Cosmetic Dentistry www.oshawadentalhouse.com
Pavestar Asphalt Solutions Paving Contractor www.pavestar.ca	Prestige Carpet Cleaning Carpet and Rug Cleaning www.prestigecarpetcleaning.ca
ProHealth Oshawa Physio & Rehab Physiotherapists www.prohealthoshawaphysio.ca	Rising Spirit Bed, Breakfast & Beyond Bed and Breakfast www.risingspirit.ca
San Jude’s Bridal Bridal Stores www.sanjudesbridal.com	Sharpe Aluminum & Siding Siding www.sharpe-aluminum-siding.ca
Skylark Tree Care Inc. Tree Services www.skylarktreecare.com	The Bollywood Tacos Restaurants – Indian Cuisine www.thebollywoodtacos.com
The Shawn Lepp Group Real Estate Real Estate Residential www.shawnlepp.com	Woitzik Polsinelli LLP Lawyer General Practice www.durhamlawyer.ca

Learn more about 2025 Durham Region Consumer Choice Award Winners HERE.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire